Update on contraception: Benefits and risks of the new formulations

Pelin Batur, MD
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Julie Elder, DO
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Mark Mayer, MD
Department of General Internal Medicine, The Cleveland Clinic

Address: Pelin Batur, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: baturp@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Pelin Batur, MD
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Julie Elder, DO
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Mark Mayer, MD
Department of General Internal Medicine, The Cleveland Clinic

Address: Pelin Batur, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: baturp@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Pelin Batur, MD
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Julie Elder, DO
Gault Women’s Health and Breast Pavilion, Department of General Internal Medicine, The Cleveland Clinic

Mark Mayer, MD
Department of General Internal Medicine, The Cleveland Clinic

Address: Pelin Batur, MD, Women’s Health Center, A10, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: baturp@ccf.org

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.